VANDERBILT UNIVERSITY MEDICAL CENTER
Biomarkers of ischemic risk in adults with sickle cell disease
Biomarkers of ischemic risk in adults with sickle cell disease is a funding opportunity from VANDERBILT UNIVERSITY MEDICAL CENTER, up to 78040, closing November 30, 2027.
Nov 30, 2027
(487d left)Overview
PROJECT SUMMARY The goal of this work is to use non-invasive quantitative neuroimaging methods to test hypotheses regarding cerebral oxygen utilization in patients with sickle cell disease (SCD) undergoing current standard treatments as well as emerging curative and disease-modifying treatments. Completion will…